SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001628280-23-017558
Filing Date
2023-05-11
Accepted
2023-05-11 16:10:27
Documents
2
Period of Report
2023-05-10

Document Format Files

Seq Description Document Type Size
1 FORM 4 wf-form4_168383580696329.html 4  
1 FORM 4 wf-form4_168383580696329.xml 4 3110
2 ROCAMBOLI POA ex-24.htm EX-24 3968
  Complete submission text file 0001628280-23-017558.txt   8551
Mailing Address C/OPARMOUNT CAPITAL 787 SEVENTH AVE 48TH FL NEW YORK NY 10019
Business Address
ROCAMBOLI STEPHEN (Reporting) CIK: 0001221451 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35986 | Film No.: 23911086

Mailing Address 3891 RANCHERO DRIVE, SUITE 150 ANN ARBOR MI 48108
Business Address 3891 RANCHERO DRIVE, SUITE 150 ANN ARBOR MI 48108 734-887-3903
Esperion Therapeutics, Inc. (Issuer) CIK: 0001434868 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations